Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $16,689 - $19,337
205 Added 6.99%
3,136 $295,000
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $217,656 - $247,698
2,931 New
2,931 $242,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $192,416 - $250,629
-2,336 Reduced 48.81%
2,450 $203,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $125,165 - $185,606
-1,447 Reduced 23.22%
4,786 $455,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $25,795 - $32,470
-253 Reduced 3.9%
6,233 $734,000
Q4 2021

Mar 11, 2022

BUY
$106.37 - $130.68 $28,613 - $35,152
269 Added 4.33%
6,486 $840,000
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $69,361 - $82,733
674 Added 12.16%
6,217 $704,000
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $39,907 - $49,865
476 Added 9.39%
5,543 $574,000
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $20,456 - $23,574
260 Added 5.41%
5,067 $424,000
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $8,746 - $11,130
122 Added 2.6%
4,807 $439,000
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $9,675 - $12,591
144 Added 3.17%
4,685 $374,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $177,568 - $237,467
3,086 Added 212.1%
4,541 $314,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $262 - $405
-5 Reduced 0.34%
1,455 $274,000
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $1,720 - $1,970
24 Added 1.67%
1,460 $341,000
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $3,065 - $3,542
55 Added 3.98%
1,436 $265,000
Q1 2019

May 10, 2019

SELL
$47.89 - $64.05 $1,724 - $2,305
-36 Reduced 2.54%
1,381 $264,000
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $1,856 - $2,277
40 Added 2.9%
1,417 $217,000
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $62,928 - $79,907
1,377 New
1,377 $240,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.